Department of Medicine

A cancer research consortium headed by investigators at Vanderbilt-Ingram Cancer Center and two other institutions have received $12 million in federal funding to help determine why African-American women die at a higher rate and have more aggressive breast cancer than white women.

Researchers at Vanderbilt University Medical Center and Duke Clinical Research Institute have received a major federal grant to study how multisite clinical trials of new drugs and therapies in children and adults can be conducted more rapidly and efficiently.

Defining the genes required for the function of insulin-producing beta cells is crucial for ongoing efforts to develop a cell-based therapy for diabetes.

Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology, has been selected to testify before members of Congress about the importance of cancer research, including early training programs for individuals interested in science.

High school students performing advanced research at Vanderbilt have the opportunity to share their findings with the scientific community through a journal of their own.

When the Mullis family straps on their helmets on June 11 to ride in the local Tour de Cure, one of a series of cycling events held nationally to benefit the American Diabetes Association (ADA), they will remember a day seven years ago that motivated their annual participation in the event.

The ability to test patients’ cancers for individual differences, mainly at the genetic level, and to make treatment decisions based on those differences is the hallmark of precision medicine, and Vanderbilt University Medical Center (VUMC) is among the leaders of this new approach to diagnosis and treatment.